Breaking News

Financial Report: Quintiles

By Kristin Brooks | February 13, 2014

Revenues up 8% in the quarter

Quintiles
 
4Q Revenues: $1.4 billion (+8%)
 
4Q Earnings: $72.9 million (+109%)
 
FY Revenues: $5.1 billion (+5%)
 
FY Earnings: $226.0 (+28%)
 
Comments: New business wins were $1.3 billion and $4.9 billion for the quarter and year ended December 31, 2013, respectively, representing a book-to-bill ratio of 1.29 for both the quarter and year, and contributed to an ending backlog of $9.9 billion. Product Development revenues were $775 million in the quarter, up 10%, and $2.9 billion for the year, up 7%. Integrated Healthcare Services revenue was $228.9 million in the quarter, down 6%, and $888.6 million for the year, down 8%.
blog comments powered by Disqus
  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision

  • The Impact of Sample Handling  and Processing on the Outcome of Bioanalytical Testing

    The Impact of Sample Handling and Processing on the Outcome of Bioanalytical Testing

    Haiko Pillu, Head Technical Operations, Life Science Services, SGS Belgium NV||September 8, 2016
    Optimizing bioanalytical procedures to get reliable results in clinical studies

  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture